The impact of TLR10 on the resolution of influenza A and B infections during the winter season

Abstract

The toll-like receptors (TLRs) is essential for innate immunity. The objectives of the present investigation were to identify the critical function of TLR10 with influenza A and B. The level of TLR10 was determined in 60 patients and 30 controls. The level of TLR10 in patients was lower than control (573.5 pg/ml vs. 1479 pg/ml), p-value 0.0001. An excellent test for predicting TLR10 as a risk factor in patients with influenza is receiver-operating characteristic (ROC) curve assessment. Patients with progressive disease can be distinguished from others by having a level of less than 987 pg/ml (Area under the curve = 0.903; 95% Confidence interval = 0.831 − 0.974; p < 0.0001; Sensitivity = 88.3%; Specificity = 86.7%). There is appositive correlation between viral load and TLR10, and the decrease level of TLR10 was more likely to have a severe infection and a progressive illness (patient vs. HC; OR = 35.41, 95% CI = 7.77- 161.32, p < 0.001). The median level was 626.5 pg/ml in influenza-like illness (ILI) as opposed to 417.5 pg/ml in severe acute respiratory infection (SARI), p = 0.00.1. To sum up, TLR10 could serve as a biochemical indicator for the severity of the sickness. Poorer outcomes in influenza patients are correlated with lower levels of TLR10, indicating that it may be utilized to inform treatment strategies and assess prognosis. Increasing our understanding of TLR10 in influenza infections is crucial for generating novel therapies that improve patient outcomes.